These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32362179)

  • 1. Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure.
    Young MK; Ng SK; Nimmo GR; Cripps AW
    Expert Opin Drug Metab Toxicol; 2020 Jul; 16(7):641-644. PubMed ID: 32362179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended.
    Young MK; Ng SK; Nimmo GR; Cripps AW
    Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):663-669. PubMed ID: 29865869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles.
    Young MK
    Hum Vaccin Immunother; 2019; 15(9):2060-2065. PubMed ID: 31116633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and pharmacokinetics of intramuscular hepatitis B immune globulin, Igantibe, for the prophylaxis of viral B hepatitis after liver transplantation.
    Filipponi F; Franchello A; Carrai P; Romagnoli R; De Simone P; Woodward MK; Paez A; Salizzoni M
    Dig Liver Dis; 2010 Jul; 42(7):509-14. PubMed ID: 19828386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubella antibodies in Australian immunoglobulin products.
    Young MK; Bertolini J; Kotharu P; Maher D; Cripps AW
    Hum Vaccin Immunother; 2017 Aug; 13(8):1952-1955. PubMed ID: 28604142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Australian immunoglobulin products meet international measles antibody titer standards?
    Young MK; Bertolini J; Kotharu P; Maher D; Cripps AW
    Hum Vaccin Immunother; 2017 Mar; 13(3):607-612. PubMed ID: 27763809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uptake and elimination of hepatitis B immunoglobulin after intramuscular administration].
    Scheiermann N; Kuwert EK
    Dtsch Med Wochenschr; 1982 Dec; 107(50):1918-22. PubMed ID: 7140575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.
    Lerman Y; Shohat T; Ashkenazi S; Almog R; Heering SL; Shemer J
    Clin Infect Dis; 1993 Sep; 17(3):411-4. PubMed ID: 8218682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany.
    Matysiak-Klose D; Santibanez S; Schwerdtfeger C; Koch J; von Bernuth H; Hengel H; Littmann M; Terhardt M; Wicker S; Mankertz A; Heininger U
    Vaccine; 2018 Dec; 36(52):7916-7922. PubMed ID: 30478003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the content of hepatitis A antibodies in immunoglobulin preparations on the effectiveness of the immunoglobulin prophylaxis of hepatitis A].
    Gorbunov MA; Sumarokov AA; Iaroshevskaia IIu; Ikoev VN; Khalitova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):86-9. PubMed ID: 6087581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of anti-hepatitis immunoglobulins on the intensity of the immunity to the hepatitis A virus].
    Perepelkin VS; Katkov AI; Semenenko TA; Mikhaĭlov MI; Vasil'eva VI
    Voen Med Zh; 1993 Feb; (2):37-8. PubMed ID: 8388594
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Anti-Hepatitis A Antibody Pharmacokinetics in Healthy Australian Subjects Receiving Standard or Weight-Based Dosing of Polyvalent Immunoglobulin.
    Young MK; Ng SK; Faddy HM; Nimmo GR
    J Clin Pharmacol; 2024 Jul; ():. PubMed ID: 38967110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gane EJ; Angus PW; Strasser S; Crawford DH; Ring J; Jeffrey GP; McCaughan GW;
    Gastroenterology; 2007 Mar; 132(3):931-7. PubMed ID: 17383422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated protective effectiveness of intramuscular immune serum globulin post-exposure prophylaxis during a measles outbreak in British Columbia, Canada, 2014.
    Bigham M; Murti M; Fung C; Hemming F; Loadman S; Stam R; Van Buynder P; Lem M
    Vaccine; 2017 May; 35(20):2723-2727. PubMed ID: 28392140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines.
    Freeman E; Lawrence G; McAnulty J; Tobin S; MacIntyre CR; Torvaldsen S
    Vaccine; 2014 Sep; 32(42):5509-13. PubMed ID: 25111168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis.
    Nelson NP
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(36):959-960. PubMed ID: 28910270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin.
    Yoshida EM; Erb SR; Partovi N; Scudamore CH; Chung SW; Frighetto L; Eggen HJ; Steinbrecher UP
    Liver Transpl Surg; 1999 Nov; 5(6):520-5. PubMed ID: 10545541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-exposure prophylaxis of viral hepatitis with immune serum globulin in an endemic area. A trial in field units of the Israel Defence Forces.
    Kark JD
    Scand J Infect Dis; 1983; 15(1):3-6. PubMed ID: 6405480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine.
    Lang J; Attanath P; Quiambao B; Singhasivanon V; Chanthavanich P; Montalban C; Lutsch C; Pepin-Covatta S; Le Mener V; Miranda M; Sabchareon A
    Acta Trop; 1998 Jul; 70(3):317-33. PubMed ID: 9777717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.